Blood test identifies Alzheimer's biomarkers years before clinical symptom onset

A study published in The Lancet indicates that a blood-based diagnostic test can identify Alzheimer's risk markers significantly earlier than current clinical standards. While the findings represent a major advancement in early detection, the clinical utility and long-term predictive accuracy of the test remain to be validated in broader, diverse populations.